CHA Bundang Hospital said it has become the first Asian medical institution to confirm the efficacy of a three-drug combination therapy -- gemcitabine, cisplatin, and Abraxane – in treating advanced biliary tract cancer.According to the hospital, the five-year survival rate for biliary tract cancer,
A research team at the Institute for Basic Science (IBS) research team has identified how autism spectrum disorders impair social interaction and provided clues for better understanding and treating declined social communication caused by autism.In a previous study, the research team found that Shan
Nearly eight out of 10 Korean doctors showed a negative stance on institutionalizing telephone medical consultation and prescription temporarily allowed during the Covid-19 pandemic, the Korea Medical Association (KMA) said in a recent report.According to a KMA survey, out of the 6,342 doctors who p
Roche said it would withdraw Parkinson’s syndrome treatment Madopar Tab. 125mg and 250mg from the Korean market, after 30 years of the drug sales since the local marketing approval in 1992.The company announced that it would voluntarily withdraw the permit for Madopar Tab. (levodopa 200mg/benserazid
Kymriah, the second-line treatment of Novartis for lymphoma, has suffered a setback in the phase 3 BVELINDA clinical study to confirm its efficacy by failing to meet the primary endpoint.On Wednesday (local time), Novartis released its updates on the BELINDA study of Kymriah on patients who had rela
As the fourth wave of the Covid-19 pandemic prolongs, calls are mounting for “overcoming the limitation of K-quarantine.” In a joint emergency statement, the Korean Society for Preventive Medicine (KSPM) and the Korean Society of Epidemiology (KSEPI) said the country should prepare for “sustainable
Chong Kun Dang said Thursday that its U.S. partner, Cara Therapeutics, has received approval from the Food and Drug Administration for uremic pruritus treatment, CR-845.Chong Kun Dang participated in developing CR-845, branded as Korsuva, after gaining exclusive rights for domestic development and s
As some countries start or consider providing booster shots of the Covid-19 vaccines, local experts said Korea might also need booster shots for high-risk groups if the immune response fades earlier than expected.The suggestion came during a briefing on vaccinations for 18-49-year-olds held by the C
Three biopharmaceutical companies developing Covid-19 vaccines or treatments received 70 percent of the government subsidies totaling more than 50 billion won ($42.2 million) in the first half of this year, according to their semiannual reports.SK Bioscience received 16.5 billion won from the govern
Korea’s obesity treatment market, which had been stagnant due to the Covid-19 outbreak, is regaining attention.According to IQVIA, a drug market research company, the size of the local obesity treatment market in the second quarter was 38.5 billion won ($32.9 million), up 2.9 percent from 37.6 billi
The government said it would ease the immune tolerance induction (ITI) treatment criteria for hemophilia A drug Hemlibra Subcutaneous Injection (ingredient: emicizumab).In January, the government expanded the reimbursement scope but added failure of ITI treatment as the criteria for reimbursement, w
The government confirmed Thursday that the Moderna vaccine supplied in Korea does not fall under the same lot numbers of contaminated vaccines as those found in Japan.Japan’s Ministry of Health, Labor and Welfare said recently it has received many reports that some of Moderna’s vaccine doses contain
Celltrion said that it has started the clinical trial of a cocktail therapy of Regkirona, a Covid-19 antibody treatment, in the European Union. Cocktail therapy is a method of increasing efficacy by mixing two or more drugs.According to Clinical Trials, a clinical information site operated by the Na
Researchers at the Korea Institute of Science and Technology (KIST) have developed a new ultrasound surgery technology that can break up biological tissues precisely and finely using variable pressure-focused ultrasound.According to KIST, attempts to replace the existing surgical operation using var
“Risk-sharing agreement, selective reimbursement, and funding for anticancer drugs do not guarantee quick access to new drugs for patients. So, the regulator should grant innovative medicines directly affecting patients’ lives the regulatory approval and a temporary drug price at the same time so th
The Korea National Enterprise for Clinical Trials (KONECT) said Wednesday that it has agreed with SK Bioscience to help recruit phase 3 clinical trial participants for the first Korean-made Covid-19 vaccine.Under the agreement, the two sides will share the information on the agency and research team
About domestic 5,000 patients with neurofibromatosis type 1 (NF1) can now benefit from a new therapeutic option for treating the rare genetic disorder with the recent approval of AstraZeneca's Koselugo (ingredient: selumetinib), an expert said.Korean patients with NF1, which lacked a cure, had to re
The Korean government is still waiting for a reply from Moderna regarding the company's vaccine supply to the country in September. According to quarantine authorities, Moderna had not yet notified them of when to supply its vaccine next month.Officials expressed concerns about Moderna reducing or f
The Hanmi Pharmaceutical Group has taken the first step toward becoming the vaccine hub of the Asia-Pacific region.According to industry insiders, Hanmi Science, the group's holding company, has recently submitted a proposal to the World Health Organization (WHO) to participate in the latter's proje
As the National Assembly is likely to pass a revision bill in a plenary session to mandate surveillance cameras in hospital operating rooms (OR), the medical community across the nation is vehemently opposing the move.Some doctors claimed that liberals who pushed for the bill had political purposes